Mirum Pharmaceuticals Earnings
NASDAQ: MIRMHealthcareBiotechnologyUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Tue, Nov 3, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.53
Mirum Pharmaceuticals earnings summary
Mirum Pharmaceuticals is scheduled to report Sep/2026 earnings on Nov 3, 2026, with analysts expecting EPS of $-0.53. In its most recent report on Aug 5, 2026 (Q2 2026), MIRM posted EPS of $-1.06. Revenue for the quarter was $176.2 million.
Across the last 16 reports, MIRM shares moved an average of 3.9% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.
Summary generated from market data by MetaCap's automated system. Methodology
MIRM earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $-1.06 | — | -0.0% |
| May 6, 2026 | — | $-13.43 | — | -4.6% |
| Feb 25, 2026 | — | $-0.10 | — | -6.5% |
| Nov 4, 2025 | — | $0.05 | — | +4.9% |
| Aug 6, 2025 | — | $-0.12 | — | +13.3% |
| May 7, 2025 | — | $-0.30 | — | +1.7% |
| Feb 26, 2025 | — | $-0.49 | — | -8.6% |
| Nov 12, 2024 | — | $-0.30 | — | +0.5% |
| Aug 7, 2024 | — | $-0.52 | — | +1.7% |
| May 8, 2024 | — | $-0.54 | — | -2.8% |
| Mar 15, 2024 | — | $-0.69 | — | -2.4% |
| Nov 2, 2023 | — | $-0.57 | — | -4.6% |
| Aug 7, 2023 | — | $-1.94 | — | -5.8% |
| May 4, 2023 | — | $-0.80 | — | -0.7% |
| Mar 8, 2023 | — | $-0.99 | — | +3.3% |
| Nov 9, 2022 | — | $-1.02 | — | -1.4% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.